Short Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Declines By 27.8%

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 139,000 shares, a decrease of 27.8% from the December 15th total of 192,400 shares. Based on an average daily trading volume, of 586,000 shares, the short-interest ratio is presently 0.2 days.

Shionogi & Co., Ltd. Stock Performance

Shares of SGIOY stock traded down $0.01 during trading hours on Friday, reaching $7.02. The company had a trading volume of 382,109 shares, compared to its average volume of 231,962. The company has a market capitalization of $11.94 billion, a P/E ratio of 11.97, a price-to-earnings-growth ratio of 4.78 and a beta of 0.21. Shionogi & Co., Ltd. has a twelve month low of $6.22 and a twelve month high of $9.11. The stock’s fifty day simple moving average is $6.97 and its 200 day simple moving average is $8.77.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.